CommercialCoverageMedium impact
Pharmacy Program Quarterly Update Changes Effective Jan. 1, 2026 – Part 1
BCBS Texas·TX · Pharmacy, Oncology, Neurology +4 more·Pharmacy
Effective date
Jan 1, 2026
We identified it
Jan 12, 2026
Summary
Blue Cross and Blue Shield of Texas is implementing pharmacy benefit changes effective January 1, 2026, including drug list exclusions, tier changes, new utilization management requirements, and dispensing limit modifications across multiple plan types. Multiple branded drugs are being excluded or moved to higher cost-sharing tiers, with generic or therapeutic alternatives specified. Members will receive notification letters regarding these changes.
Action Required
By December 15, 2025: Billing and clinical teams must review the complete drug list changes published on the BCBSTX member website to identify medications commonly prescribed in this practice. Update pharmacy benefit verification procedures to confirm coverage status for affected drugs. Providers should review therapeutic alternatives listed for excluded medications (e.g., HUMIRA alternatives for adalimumab-adaz exclusions, Trulance for Linzess, generic lenalidomide for Revlimid). Train front-desk and billing staff to inform patients of potential coverage changes when scheduling or processing prescriptions. Establish process for obtaining prior authorizations for drugs with new utilization management requirements. Flag claims for affected drugs during pre-submission review to prevent denials. Before January 1, 2026: Communicate with patients currently on excluded or tier-changed medications to allow time for transition to alternative therapies. Document all discussions regarding formulary changes in patient records. Update encounter templates to reflect new pharmacy requirements.